Trialled drug 'could treat one in seven cancers'

15 December 2011

A new cancer treatment drug could be used for 70 per cent of all cancers, according to latest reports.

Scientists have developed a vaccine that could tackle cancers, including prostate, pancreatic, bowel and ovarian.

Furthermore, testing has suggested that tumours that are not responsive to the best medicine currently used - including the drug Herceptin - could be reactive to the new treatment.

Tests have been done only on mice so far, but it is expected that a clinical trial of the vaccine will shortly follow.

Professor Geert-Jan Boons, co-author of the study, said: "This vaccine elicits a very strong immune response. It activates all three components of the immune system to reduce tumour size by an average of 80 per cent."

He added that the most significant result found was in mice with breast tumours, where the lump considerably reduced in size.

According to herceptin.com, around one in four breast cancer patients has HER2+ breast cancer, which is treatable with the drug Herceptin.

Posted by Philip Briggs

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cancer

© Spire Healthcare Group plc (2016)